GGrantIndex
← Leaderboards

Cesar Augusto Arias

Methodist Hospital Research Institute

$18,609,748
Attributed
$18,609,748
Total exposure
14
Grants
14
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $5.3M · FY200825
$10M$7.5M$5M$2.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$30,648,160 · 15

By mechanism

P01$15,546,506 · 3
R01$10,693,081 · 4
K24$1,483,155 · 1
T32$1,135,575 · 2
R21$1,105,926 · 3
R00$593,267 · 1

Top collaborators

Most similar at Methodist Hospital Research Institute

Same institution · by research overlap

Others in their field

Top investigators on “Pathogen

Research focus

PathogenInfectionOrganismAntibioticsGenomicsVancomycin Resistant EnterococcusAntibiotic ResistanceAffectMulti-Drug Resistant PathogenCritical IllnessHospitalsMulti-Drug ResistancePhenotypeAntimicrobialInsightPublic Health RelevanceResistanceAntimicrobial ResistancePublic HealthEnterococcusPredispositionIn VitroBaseMediating

Grant awards (60)

Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,377,848
P01 · FY2025 · AI · contact PI
Project 1: Genomics of Pathobionts and Transition From Colonization to Infection$482,586
P01 · FY2025 · AI · contact PI
Clinical Impact of the Cefazolin Inoculum Effect$425,805
R01 · FY2025 · AI · contact PI
Antimicrobial Resistance Training Program in the Texas Medical Center (AMR-TPT)$347,141
T32 · FY2025 · AI · contact PI
P01 Administrative Core$179,186
P01 · FY2025 · AI · contact PI
Clinical Impact of the Cefazolin Inoculum Effect$161,779
R01 · FY2025 · AI · contact PI
POR and Training Program on Multidrug-Resistant Organisms$126,566
K24 · FY2025 · AI · contact PI
Clinical Impact of the Cefazolin Inoculum Effect$54,000
R01 · FY2025 · AI · contact PI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,406,527
P01 · FY2024 · AI · contact PI
VENOUS: A translational study of enterococcal bacteremia$747,390
R01 · FY2024 · AI · contact PI
Clinical Impact of the Cefazolin Inoculum Effect$641,584
R01 · FY2024 · AI · contact PI
Project 1: Genomics of Pathobionts and Transition From Colonization to Infection$501,388
P01 · FY2024 · AI · contact PI
Antimicrobial Resistance Training Program in the Texas Medical Center (AMR-TPT)$342,204
T32 · FY2024 · AI · contact PI
P01 Administrative Core$233,961
P01 · FY2024 · AI · contact PI
POR and Training Program on Multidrug-Resistant Organisms$126,566
K24 · FY2024 · AI · contact PI
VENOUS: A translational study of enterococcal bacteremia$774,754
R01 · FY2023 · AI · contact PI
Clinical Impact of the Cefazolin Inoculum Effect$687,709
R01 · FY2023 · AI · contact PI
POR and Training Program on Multidrug-Resistant Organisms$126,566
K24 · FY2023 · AI · contact PI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,411,532
P01 · FY2022 · AI · contact PI
VENOUS: A translational study of enterococcal bacteremia$783,059
R01 · FY2022 · AI · contact PI
The LiaFSR system and antimicrobial peptide resistance in enterococci$489,288
R01 · FY2022 · AI · contact PI
P01 Administrative Core$382,893
P01 · FY2022 · AI · contact PI
Project 1: Genomics of Pathobionts and Transition From Colonization to Infection$375,833
P01 · FY2022 · AI · contact PI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,378,848
P01 · FY2021 · AI · contact PI
VENOUS: A translational study of enterococcal bacteremia$785,566
R01 · FY2021 · AI · contact PI
Project 1: Genomics of Pathobionts and Transition From Colonization to Infection$519,480
P01 · FY2021 · AI · contact PI
The LiaFSR system and antimicrobial peptide resistance in enterococci$454,282
R01 · FY2021 · AI · contact PI
P01 Administrative Core$155,995
P01 · FY2021 · AI · contact PI
POR and Training Program on Multidrug-Resistant Organisms$126,566
K24 · FY2021 · AI · contact PI
POR and Training Program on Multidrug-Resistant Organisms$125,366
K24 · FY2021 · AI · contact PI
The LiaFSR system and antimicrobial peptide resistance in enterococci$33,998
R01 · FY2021 · AI · contact PI
Dynamics of Colonization and Infection by Multidrug-resistant Pathogens in Immunocompromised and Critically Ill Patients (DYNAMITE)$2,463,657
P01 · FY2020 · AI · contact PI
VENOUS: A translational study of enterococcal bacteremia$783,049
R01 · FY2020 · AI · contact PI
The LiaFSR system and antimicrobial peptide resistance in enterococci$641,586
R01 · FY2020 · AI · contact PI
Project 1: Genomics of Pathobionts and Transition From Colonization to Infection$507,273
P01 · FY2020 · AI · contact PI
Texas Medical Center Training Program in Antimicrobial Resistance$302,076
T32 · FY2020 · AI · contact PI
Molecular basis of the cefazolin inoculum effect$233,638
R21 · FY2020 · AI · contact PI
POR Program on Genomic Prediction of Antimicrobial Resistance in VRE$170,305
K24 · FY2020 · AI · contact PI
P01 Administrative Core$169,499
P01 · FY2020 · AI · contact PI
The LiaFSR system and antimicrobial peptide resistance in enterococci$643,198
R01 · FY2019 · AI · contact PI
Molecular basis of the cefazolin inoculum effect$207,913
R21 · FY2019 · AI · contact PI
POR Program on Genomic Prediction of Antimicrobial Resistance in VRE$170,305
K24 · FY2019 · AI · contact PI
Texas Medical Center Training Program in Antimicrobial Resistance$144,154
T32 · FY2019 · AI · contact PI
The LiaFSR system and antimicrobial peptide resistance in enterococci$658,280
R01 · FY2018 · AI · contact PI
POR Program on Genomic Prediction of Antimicrobial Resistance in VRE$170,305
K24 · FY2018 · AI · contact PI
POR Program on Genomic Prediction of Antimicrobial Resistance in VRE$170,305
K24 · FY2017 · AI · contact PI
Targeting Cell Membrane Adaptation in Multidrug-Resistant Enterococcus faecium$107,055
R21 · FY2017 · AI · contact PI
Characterization of LiaR from multidrug-resistant E. faecium$193,230
R21 · FY2016 · AI · contact PI
POR Program on Genomic Prediction of Antimicrobial Resistance in VRE$170,305
K24 · FY2016 · AI · contact PI
Targeting Cell Membrane Adaptation in Multidrug-Resistant Enterococcus faecium$118,860
R21 · FY2016 · AI · contact PI
Molecular Mechanisms Of Daptomycin Resistance In Enterococci$286,659
R01 · FY2015 · AI · contact PI
Characterization of LiaR from multidrug-resistant E. faecium$245,230
R21 · FY2015 · AI · contact PI
Molecular Mechanisms Of Daptomycin Resistance In Enterococci$418,063
R01 · FY2014 · AI · contact PI
Molecular Mechanisms Of Daptomycin Resistance In Enterococci$394,154
R01 · FY2013 · AI · contact PI
Molecular Mechanisms Of Daptomycin Resistance In Enterococci$421,297
R01 · FY2012 · AI · contact PI
Molecular Mechanisms Of Daptomycin Resistance In Enterococci$407,581
R01 · FY2011 · AI · contact PI
Enterococcus faecium virulence: A molecular and therapeutic approach$249,000
R00 · FY2010 · AI · contact PI
Enterococcus faecium virulence: A molecular and therapeutic approach$95,267
R00 · FY2010 · AI · contact PI
Enterococcus faecium virulence: A molecular and therapeutic approach$249,000
R00 · FY2009 · AI · contact PI
Enterococcus faecium virulence: A molecular and therapeutic approach$90,650
K99 · FY2008 · AI · contact PI